March 14, 2017
Wellesley, Mass., March 14, 2017— BCC Research has published an important analysis of the development of— and prospects for— the companion diagnostic (CDx) market.
Key to making personalized medicine a reality, companion diagnostics are playing a critical role in the accurate diagnosis of disease and enabling the efficient use of targeted therapies. This highly-complex sector continues to innovate, as exemplified by the development of liquid biopsy technology which introduces a new, non-invasive and cost-effective way for clinicians to make treatment adjustments.
“As genomic research identifies new disease states and patient sub populations, the pharma industry and clinicians must be able to respond with specific targeted medicines. Companion diagnostics are changing the way powerful new targeted medicines are utilized to the benefit of patients, physicians and health payers,” said report author and BCC Research Senior Editor, Healthcare Robert G. Hunter.
The global market for companion diagnostics was estimated to be US$1.6 billion in 2015, and nearly US$1.9 billion at the end of 2016. Driven by the growth in targeted therapies coming to market and wider use of CDx is multiple therapy areas, the market is expected to accelerate to reach US$6.09 billion by the end of 2021, growing at a CAGR of 25.1% for the period 2016 through 2021.
BCC Research’s Companion Diagnostics: Technologies and Global Markets is a comprehensive and highly detailed 363-page market research report which presents expert analysis of the current market, forecasted future value, market environment, technical innovations and companies which are shaping the critical companion diagnostic sector.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at firstname.lastname@example.org.
Companion Diagnostics: Technologies and Markets( BIO077C )
Publish Date: Mar 2017
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.